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Received 30 August 2007; received in revised form 4 February 2008; accepted 6 February 2008AbstractObjective: The objective of this prospective study was to compare the clinical value of procalcitonin (PCT) and C-reactive protein (CrP) plasma
concentrations in their postoperative course after decortication. Methods: Twenty-two patients requiring surgery for pleural empyema were
chosen for this prospective study. Routine blood samples including CrPand PCT plasma concentrations were taken before the operation and on the
1st, 2nd, 3rd, and 7th postoperative day. Results: Due to infection PCTand CrP were elevated preoperatively. In the postoperative course both
PCTand CrP reached peak-levels on day 2 with values up to 43.55 ng/ml and 384.00 mg/l, respectively. In PCT the rise was followed by a clear
decrease in 20 (90.9 %) patients until day 7. In contrast the CrP levels decreased slowly and only seven (54.5%) patients had values of 100 mg/l or
below on day 7. PCT showed a better correlation with the clinic in case of septic course than CrP does. Conclusions: PCT reflects postoperative
clinical course more accurately than CrP. Therefore, PCT is a more appropriate laboratory parameter to monitor patients after surgery for pleural
empyema.
# 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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The main goal of surgery in the treatment of pleural
empyema is to control the infection [1]. Therefore, a rapidly
obtainable and accurate laboratory marker capable of
distinguishing persistent infection from SIRS or sepsis in
the postoperative course would be clinically useful. After
surgery C-reactive protein (CrP) is widely used to monitor the
postoperative course, especially with regard to infection.
However, several trials showed a lower sensitivity in the
(early) postoperative period for CrP in comparison to
procalcitonin (PCT) that has become increasingly popular
as a marker of infection after surgical procedures [2,3].
Until now no study has evaluated the time course and
clinical relevance of changes in PCT in patients undergoing
surgery for pleural empyema. The aim of this prospective
pilot study was to investigate the accuracy of PCT in
comparison to CrP as a marker of postoperative course and
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Twenty-two patients undergoing surgery for pleural
empyema at the Division of Thoracic Surgery, Inselspital
Bern, were chosen for this prospective pilot study.
Inclusion criteria consisted of clinically proven pleural
empyema following pneumonia and secondary infected
posttraumatic pleural effusion. Definition of pleural
empyema was based on the following criteria: presence
of micro-organisms in pleural fluid Gram stain or culture,
pleural pH less than 7.2, radiographic features of empyema
as pleural enhancement in CT scan, or intraoperative
findings of purulent liquid in the pleural space. Patients
with empyema after lung resections or with tuberculous
empyema and patients on immunosuppressive therapy
were excluded from the trial.
Complete lung decortication was performed through a
muscle-sparing lateral thoracotomy without rib resection
and with preservation of the latissimus and serratus
muscles. The whole fibrous peel encasing the lung and
diaphragm was removed. Resection of the parietal peel
was done by an extrapleural dissection. To ensure
adequate drainage of the pleural space three chest tubes
were placed.Surgery. Published by Elsevier B.V. All rights reserved.
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Fig. 1. PCT levels before and after surgery.
Fig. 2. CrP levels before and after surgery.Routine blood examinations including CRP and PCT were
sampled before operation and on 1st, 2nd, 3rd, and 7th
postoperative day.
2.1. Assays
PCTwas measured using the quantitative Kryptor-Test PCT
(Brahms Diagnostica AG, Germany) with a lower detection
limit of 0.06 ng/ml. All blood samples were collected,
prepared, and frozen according to the manufacturers
instructions. The PCT measurement was carried out at a
later date. Therefore the PCT values were not available at
time of hospitalisation.3. Statistical analysis
For statistical analysis the Wilcoxon rank sum test was
used. To compensate for the multiple testing situation the p
values were adjusted using the procedure according to Holm.4. Results
The median age of the 22 patients (10 woman and 12 men)
was 58.0 years and ranged from 24 to 84 years. The leading
cause of the pleural empyema was pneumonia (n = 17)
followed by a thoracic trauma in five cases.
4.1. PCT
In the postoperative coursePCTrose to apeak level onday 2
(median 0.85 range: 0.14—43.55 ng/ml) followed by a
decrease until day 7 (median 0.17 ng/ml, range: 0.04—
2.66 ng/ml) (Fig. 1). On day 3, 54.5% of the patients had
reached PCT levels of 0.5 ng/ml or below.Onday 7 the number
of patientswith PCT values<0.5 ng/mlwas 19 (86.4%) (Fig. 1).Table 1
PCT and CrP course in patients with and without septic signs
Preoperative 1st 2nd
PCT 1 0.29 (0.03—2.89) 2.25 (1.94—43.55) 16.4
PCT 2 0.12 (0.04—1.29) 0.26 (0.15—1.66) 0.3
CrP 1 144 (5—477) 198 (64—262) 224 (
CrP 2 136 (3—501) 128 (44—486) 236 (
PCT 1: patients with septic signs; PCT 2: patients without septic signs; CrP 1: pat
preoperative and postoperative days 1, 2, 3, and 7.In some patients PCT was elevated excessively: 11
patients (50.00%) had PCT levels of higher than 0.5 ng/ml
on day 1, 14 patients (63.6%) on day 2, and 10 (45.4%) on
day 3. Values of more than 2 ng/ml were observed in four
(18.2%), seven (31.8 %), and three (13.6%) cases on day 1,
2, and 3 respectively. Four patients (18.2%) developed
levels of over 10 ng/ml in the postoperative course. In
three of these four patients the levels decreased to less
than 10 ng/ml by day 7. One patient had a PCT of 2.66 ng/
ml on day 7, another patient a PCT of 36.39 ng/ml. This
patient developed recurrent pleural effusion (see below).
In patients with a PCT level of 10.0 ng/ml or higher the
decrease was slower than in the patients with PCT values
below 10.0 ng/ml. Six of seven patients (85.7%) with values
of more than 2 or even 10 ng/ml in the postoperative
course also had the clinical signs of a sepsis (according to
the guidelines of the Consensus Conference of American
College of Chest Physicians and of the Society of Critical
Care Medicine) (Table 1) [4,5]. PCT values in case of sepsis
were significant higher than in the other patients on day 1,
2, and 3 ( p = 0.001).
4.2. CrP
CrP showed a median value of 144.50 mg/l before surgery
(range: 3.00—501.00 mg/l). CrP levels also peaked on the
second postoperative day (median 226.50, range: 84.00—
390.00 mg/l). Thereafter the values decreased slowly. On
day 3 after surgery, 10 patients (45.4%) still had levels of
200 mg/l and more, eight patients (36.4%) levels of 100 mg/l
or more. On day 7 only 12 patients (54.5%) had CrP levels of
100 mg/l or below whereas in 10 patients the levels were
100 mg/l or higher (up to 261 mg/l) (Fig. 2, Table 1). In the
patients with septic course and very high PCT values the CrP
did not show significantly different values to the other ones
( p = 0.30).3rd 7th
(1.94—43.55) 1.71 (0.54—36.81) 0.27 (0.17—36.39)
0 (0.15—1.40) 0.22 (0.07—0.92) 0.11 (0.03—0.43)
84—312) 180 (66—285) 112 (39—261)
98—390) 198 (44—381) 56 (3—207)
ients with septic signs; CrP 2: patients without septic signs median (range)
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Fig. 3. Course of PCT and CrP in case of complication.4.3. Complications
No patient died. Complications occurred in two patients
(9.1%): one required wound-revision due to a wound infection
14 days postoperatively and one patient was readmitted with
fever and recurrent pleural effusion, which was treated
conservatively. In the first case both the PCT and the CrP
showed decreasing values until the day of discharge. The
wound infection occurred 2 weeks later. In the other patient
a continuously high level of PCT (36.39 ng/ml) was observed
whereas CrP values fell clearly (Fig. 3). The patient was
discharged in good clinical condition. The readmission
occurred one week later. A conservative therapy was
successfully carried out with antibiotics.
4.4. Microbiology/antibiotics
The microbiological detection of bacteria succeeded in
seven cases (31.8%) only.
Antibiotic therapy was continued in all patients after
operation. Fourteen patients (63.6%) were also treated with
antibiotics after discharge due to persistently high CrP-
values. In nine of these 14 cases (64.3%) the CrP was above
100 mg/l. At the same time, the median PCT of the 14
patients was 0.17 ng/ml. Only two of them (14.3%) had higher
PCT-levels, which might be interpreted as a sign of persistent
infection. One of these patients had to be admitted later in
the follow-up. The course of the other patient was
uneventful.5. Discussion
Today non-tuberculotic bacterial pneumonia is the leading
cause of pleural empyema. It is estimated that nearly 5% of the
1.2 million annual cases of pneumonia worldwide are
complicated with a pleural empyema, which could lead to
sepsiswith serious consequences if not adequately treated [6].
About 40—65% of the patients are not cured of their empyema
by conservative therapy, i.e. chest tube drainage, antibiotics,
urokinase, and therefore require surgical intervention (dec-
ortication) [7,8]. In the postoperative course clinical and
laboratory parameters are needed to reflect the response to
therapy in the follow-up. The aim of this trial was to
investigate the course of PCT in comparison to CrP afterdecortication. Several studies have underscored the value of
PCT in a variety of clinical conditions. Simon et al. and Castelli
et al. used PCT for identifying infectious processes [9,10]. PCT
and its characteristic course for critically ill patients including
sepsis was examined in studies [11]. PCT guided therapy was
the object of the trials by Christ-Crain et al. and Sandek et al.
in 2004 [12,13]. All these trials confirm that PCT is a suitable
parameter to detect and to evaluate the course of bacterial,
fungal or parasitic infections. It appears to be more helpful in
the early diagnosis of postoperative infections and in the
differentiation of SIRS and infection than CrP [14]. However to
date, little is known about the value of PCT measurements in
thoracic surgery.Meisner et al. in 1998 andMolter et al. in 2003
examined the postoperative course of PCT values including
patients undergoing different types of thoracic procedures
[3,14]. A study dealing exclusively with thoracic surgery was
published in 2005 by Falcoz et al. [15]. In this trial PCT was
significantly higher in patients with a postoperative infection
than in patients with no postoperative infection. The authors
found that PCTcan provide more accurate information about
the postoperative course than CRP does, and that pathological
values are detected before the occurrence of clinical infection
[15]. In pleural empyema nothing is known about the
postoperative course of PCT in comparison to CrP. The
situation in pleural empyema is different to all the mentioned
studies dealing in particular with the occurrence of an
infection after an operation: in pleural empyema an elevated
CrP and PCT value is expected preoperatively because of the
infection. But after the removal of damaged and infectious
tissue both the CrPand thePCT values should decrease rapidly.
Theamount and thepatternofdecreasecouldact as indicators
for the success of the operation more than radiological
changes. In general PCT was elevated preoperatively with a
rangeup to2.89 ng/ml as signof a systemic infection.Only two
(9.1%) of the patients showed PCT levels lower than 0.05 ng/
ml. In the postoperative course PCTrose to a peak-level on day
2 and of 43.55 ng/ml followed by a clear decrease until day 7.
High PCT levels over 10 ng/ml are an indicator for severe
systemic inflammation or sepsis due to bacteraemia. In these
patients with high levels of over 10 ng/ml the decrease of PCT
was slower than in the group of patients with values between
2 ng/ml and 10 ng/ml. Several studies have suggested the
correlation between PCT levels and the severity of infection
[16—20]. In the presented trial PCTalso had a good correlation
with the postoperative course in case of SIRS or sepsis: Patients
with very high PCT values showed clinical signs of a SIRS or
sepsiswhichmaybedue to transient orpersistent bacteraemia
after decortication. In case of septic course the PCT levels
were significant higher than in patients without septic events.
One of two patients with elevated levels of PCTon day 7 had a
complication. Until now it has been difficult to recommend
universal cut-off points for PCT, which clearly differentiate a
normal from a complicated postoperative course. In the
literature the cut-off points range from 1 ng/ml to 5 ng/ml
[16,21,22]. Sponholz et al. [16] advise interpreting PCT levels
according to the clinical context. In general, dynamics of PCT
levels, rather than the absolute values, may be more
important for identifying patients with persistent infection
or infectious complications after surgery. Because all PCT
values were not available during hospitalisation the clinical
decisions were made with the help of the CrP values only. CrP
G.L. Carboni et al. / European Journal of Cardio-thoracic Surgery 33 (2008) 777—780780values were elevated before surgery (81.8%) but in contrast to
PCT they decreased very slowly. High CrP values are the cause
of why more than half of the patients (63.6%) received
antibiotics at time of discharge for the next 1 or 2 weeks. In 12
of these 14 patients the PCT level was lower than 0.5 ng/ml. If
thePCTvalues hadbeenavailablemostof thesepatients (up to
85.7%!) would not have received antibiotics. So the use of PCT
instead of CrP in the postoperative course after decortication
could save at least 7 days of antibiotic treatment. A meta-
analysis by Simon et al. showed that the PCT level was more
sensitive (88% vs 75%) and more specific (81% vs 67%) than the
CRP level in differentiating bacterial from non-infective
causes of inflammation [9].
Furthermore in patients with a sepsis after the operation
CrP was not more elevated than in all the other patients.
Several trials have proved the poor diagnostic value of CRP in
the postoperative period especially if compared with PCT.
Macrina et al. [2] used CrP to follow septic patients and found
that CrP was unable to predict the outcome of disease or
severity.6. Conclusions/summary
Although there are only a small number of patients with
pleural empyema due to different causes in this trial PCT
seems to describe more accurately the postoperative course
after successful decortication than CrP. After surgery for
pleural empyema the main focus should be on the dynamics
of PCT levels, rather than on the absolute values. By using
the Kryptor method a lower detection concentration of
0.06 ng/ml allows a higher accuracy. PCT is a more
appropriate laboratory diagnostic parameter than CRP to
monitor the course of patients after surgery for pleural
empyema.Acknowledgment
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